Profil
Richard W.
Krawiec worked as VP-Investor Relations & Corporate Affairs at Amylin Pharmaceuticals, La Jolla Pharmaceutical Co., and IDEC Pharmaceuticals Corp.
He also worked as VP-Investor Relations & Corporate Communications at Jazz Pharmaceuticals (EUSA Pharma USA), Inc. He was VP-Corporate Affairs & Head-Investor Relations at Progenics Pharmaceuticals, Inc. Dr. Krawiec received an undergraduate degree from Boston University and a doctorate degree from the University of Rhode Island.
Anciens postes connus de Richard W. Krawiec
| Sociétés | Poste | Fin |
|---|---|---|
| PROGENICS PHARMACEUTICALS, INC. | Public Communications Contact | 01/12/2009 |
Jazz Pharmaceuticals (EUSA Pharma USA), Inc.
Jazz Pharmaceuticals (EUSA Pharma USA), Inc. BiotechnologyHealth Technology Develops and markets biopharmaceutical products | Public Communications Contact | 01/01/2001 |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes targeted immunotherapies for the treatment of cancer and autoimmune diseases | Public Communications Contact | - |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Public Communications Contact | - |
| LA JOLLA PHARMACEUTICAL COMPANY | Public Communications Contact | - |
Formation de Richard W. Krawiec
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Jazz Pharmaceuticals (EUSA Pharma USA), Inc.
Jazz Pharmaceuticals (EUSA Pharma USA), Inc. BiotechnologyHealth Technology Develops and markets biopharmaceutical products | Health Technology |
La Jolla Pharmaceutical Co.
La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes patients life-threatening conditions | Health Technology |
Progenics Pharmaceuticals, Inc.
Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for prostate cancer | Health Technology |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Rhode Island
University of Rhode Island Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes targeted immunotherapies for the treatment of cancer and autoimmune diseases | Health Technology |
















